Literature DB >> 14514672

Signal-induced ubiquitination of I kappaB Kinase-beta.

Robert S Carter1, Kevin N Pennington, Bradley J Ungurait, Pia Arrate, Dean W Ballard.   

Abstract

Initiation of the genetic programs for inflammation and immunity involves nuclear mobilization of transcription factor NF-kappaB. This signal-dependent process is controlled in part by the beta-catalytic subunit of IkappaB kinase (IKKbeta), which marks IkappaBalpha and other cytoplasmic inhibitors of NF-kappaB for proteolytic destruction. The catalytic activity of IKKbeta is stimulated by pathologic and physiologic inducers of NF-kappaB, such as the Tax oncoprotein and proinflammatory cytokines. We now report evidence that these NF-kappaB inducers target IKKbeta for conjugation to ubiquitin (Ub) in mammalian cells. The apparent molecular size of modified IKKbeta is compatible with monoubiquitination rather than attachment of a multimeric Ub chain. The modification is contingent upon signal-induced phosphorylation of the activation T loop in IKKbeta at Ser-177/Ser-181. The formation of IKKbeta-Ub conjugates is disrupted in cells expressing YopJ, a Ub-like protein protease that interferes with the NF-kappaB signaling pathway. These findings indicate an important mechanistic link between phosphorylation, ubiquitination, and the biologic action of IKKbeta.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14514672     DOI: 10.1074/jbc.M310686200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNFα-induced NF-κB activation via mediating TAK1 degradation.

Authors:  Yihui Fan; Yi Shi; Shangfeng Liu; Renfang Mao; Lei An; Yanling Zhao; Hong Zhang; Fuchun Zhang; Guotong Xu; Jun Qin; Jianhua Yang
Journal:  Cell Signal       Date:  2012-03-03       Impact factor: 4.315

Review 2.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

Review 3.  Ubiquitylation and cell signaling.

Authors:  Kaisa Haglund; Ivan Dikic
Journal:  EMBO J       Date:  2005-09-08       Impact factor: 11.598

4.  The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway.

Authors:  Axel Thiefes; Alexander Wolf; Anneke Doerrie; Guntram A Grassl; Kunihiro Matsumoto; Ingo Autenrieth; Erwin Bohn; Hiroaki Sakurai; Rainer Niedenthal; Klaus Resch; Michael Kracht
Journal:  EMBO Rep       Date:  2006-07-14       Impact factor: 8.807

5.  Downregulation of active IKK beta by Ro52-mediated autophagy.

Authors:  Motoko Niida; Makoto Tanaka; Tetsu Kamitani
Journal:  Mol Immunol       Date:  2010-06-02       Impact factor: 4.407

Review 6.  When ubiquitin meets NF-κB: a trove for anti-cancer drug development.

Authors:  Zhao-Hui Wu; Yuling Shi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  Ubiquitin-like domain of IKKβ regulates osteoclastogenesis and osteolysis.

Authors:  Yanhong Zhang; Jesse E Otero; Yousef Abu-Amer
Journal:  Calcif Tissue Int       Date:  2013-05-18       Impact factor: 4.333

8.  Ro52-mediated monoubiquitination of IKK{beta} down-regulates NF-{kappa}B signalling.

Authors:  Keiji Wada; Motoko Niida; Makoto Tanaka; Tetsu Kamitani
Journal:  J Biochem       Date:  2009-08-12       Impact factor: 3.387

9.  In vitro activation of the IkappaB kinase complex by human T-cell leukemia virus type-1 Tax.

Authors:  Sohini Mukherjee; Veera S Negi; Gladys Keitany; Yuetsu Tanaka; Kim Orth
Journal:  J Biol Chem       Date:  2008-01-26       Impact factor: 5.157

10.  Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling.

Authors:  Rohit Mittal; Sew-Yeu Peak-Chew; Harvey T McMahon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.